Immunotherapy for glioma: Current management and future application

Gliomas are intrinsic brain tumors that originate from neuroglial progenitor cells. Conventional therapies, including surgery, chemotherapy, and radiotherapy, have achieved limited improvements in the prognosis of glioma patients. Immunotherapy, a revolution in cancer treatment, has become a promisi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer letters Jg. 476; S. 1 - 12
Hauptverfasser:	Xu, Shengchao, Tang, Lu, Li, Xizhe, Fan, Fan, Liu, Zhixiong
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Ireland Elsevier B.V 28.04.2020 Elsevier Limited
Schlagworte:	Antibodies Apoptosis Blood-brain barrier Brain cancer Brain Neoplasms - immunology Brain Neoplasms - pathology Brain Neoplasms - therapy Brain tumors Cancer therapies Central nervous system Checkpoint Chemotherapy Clinical trials Cytotoxicity Disease Management FDA approval Glioma Glioma - immunology Glioma - pathology Glioma - therapy Humans Immunotherapy Immunotherapy - methods Ligands Medical prognosis Medical research Melanoma Oncolytic virus Progenitor cells Prognosis Radiation therapy Stem cells Surgery Tumors Vaccine Vascular endothelial growth factor Checkpoint Vaccine Oncolytic virus Glioma Immunotherapy
ISSN:	0304-3835, 1872-7980, 1872-7980
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!